this post was submitted on 05 Aug 2025
9 points (90.9% liked)

Medicine Canada

298 readers
1 users here now

A community for Canadian physicians and medical professionals


🍁 While this community is intended for Canadian discussions, you are free to post about other medical systems. We're all in this together :)



Related Communities

For better links and descriptions, see the pinned post in the Medical Community Hub (!medicine@lemmy.world)


Rules

  1. No requests for professional advice or general medical information. Please do not solicit medical advice or share personal health anecdotes about yourself or others.

  2. No promotions, advertisements, surveys, or petitions.

  3. Link to high-quality, original research whenever possible: Posts which rely on or reference scientific data (e.g. an announcement about a medical breakthrough) should link to the original research in peer-reviewed medical journals or respectable news sources as judged by the moderators. Sensationalized titles, misrepresentation of results, or promotion of blatantly bad science may lead to removal.

  4. Act professionally and decently: /r/medicine is a public forum that represents the medical community and comments should reflect this. Please keep disagreement civil and focused on issues.

  5. Protect patient confidentiality. Please anonymize cases and remove any patient-identifiable information.

  6. No memes or low-effort posts: Memes, image links (including social media screenshots), images of text, or other low-effort posts or comments are not allowed.

These rules have been modelled after /r/medicine. While some rules were modified or skipped as this is a much smaller community, we can revisit the rules as we go. Thank you :)

founded 2 years ago
MODERATORS
 

Sandoz Canada highlighted five of its generic drugs that Health Canada has been reviewing since 2023, four of which would trigger a reduction in price. The company gets a lot of its drugs made at the Delpharm manufacturing facility in Boucherville.

Health Canada is taking longer to assess generic drug applications, lengthening the wait until the cheaper pharmaceuticals can come to market, new data show.

The federal regulator’s delays mean that it takes more time before patients are able to access some medications, and also that both public and private insurers may spend more on drugs before the less expensive alternatives become available.


From The Globe and Mail via this RSS feed

top 1 comments
sorted by: hot top controversial new old
[–] MadMadBunny@lemmy.ca 3 points 1 week ago

And, that drugs are safer, being thoroughly tested?